Cogent Biosciences, Inc. Balance Sheet

Balance Sheet Dec2017 Dec2018 Dec2019 Dec2020
Assets
Assets 49.12M85.93M49.42M250.92M
Current Assets
Cash & Equivalents 36.89M75.02M37.42M242.19M
Short-term Investments 12.69M22.92M
Cash & Current Investments 49.58M97.95M37.42M242.19M
Receivables - Net 0.83M1.67M2.00M
Receivables 0.83M1.67M2.00M
Prepaid Assets 0.51M0.74M1.17M2.72M
Current Assets 42.38M81.00M40.59M244.91M
Non-Current Assets
Property, Plant & Equipment (Net) 4.11M3.25M1.86M0.13M
Other Non-Current Assets 1.37M1.25M1.25M1.25M
Non-Current Assets 6.74M4.92M8.83M6.00M
Liabilities
Current Liabilities
Accounts Payables 1.35M1.52M3.18M0.73M
Payables 1.35M1.52M3.18M0.73M
Accumulated Expenses 2.95M5.48M7.13M4.78M
Other Accumulated Expenses 0.18M0.31M
Current Leases 1.62M2.05M
Current Deferred Revenue 6.89M17.95M1.31M
Total Current Liabilities 11.19M24.95M13.25M13.09M
Non-Current Liabilities
Non-Current Deffered Revenue 8.71M0.75M
Preferred Stock Liabilities 77.15M110.88M
Operating Leases 4.41M3.15M
Other Non-Current Liabilities 5.53M
Total Non-Current Liabilities 10.72M
Liabilities
Total Liabilities 20.81M25.69M17.66M16.25M
Shareholder's Equity
Common Equity -48.85M60.23M31.76M234.67M
Shareholder's Equity -48.85M60.23M31.76M234.67M
Liabilities and Shareholders Equity 49.12M85.93M49.42M250.92M
Retained Earnings -51.34M-92.06M-123.89M-198.70M
Preferred Shares 110.88M
Treasury Shares 0.09M